KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Short term Debt (2016 - 2025)

Historic Short term Debt for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $455.0 million.

  • Idexx Laboratories' Short term Debt rose 8200.0% to $455.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $455.0 million, marking a year-over-year increase of 8200.0%. This contributed to the annual value of $250.0 million for FY2024, which is 0.0% changed from last year.
  • Per Idexx Laboratories' latest filing, its Short term Debt stood at $455.0 million for Q3 2025, which was up 8200.0% from $579.0 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Short term Debt high stood at $633.0 million for Q3 2022, and its period low was $75.0 million during Q3 2021.
  • For the 5-year period, Idexx Laboratories' Short term Debt averaged around $297.2 million, with its median value being $250.0 million (2022).
  • Its Short term Debt has fluctuated over the past 5 years, first plummeted by 7432.93% in 2021, then soared by 74411.25% in 2022.
  • Idexx Laboratories' Short term Debt (Quarter) stood at $75.0 million in 2021, then soared by 233.35% to $250.0 million in 2022, then changed by 0.0% to $250.0 million in 2023, then changed by 0.0% to $250.0 million in 2024, then soared by 82.0% to $455.0 million in 2025.
  • Its Short term Debt stands at $455.0 million for Q3 2025, versus $579.0 million for Q2 2025 and $319.5 million for Q1 2025.